{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T15:00:22Z","timestamp":1774364422616,"version":"3.50.1"},"reference-count":40,"publisher":"Deutscher Arzte-Verlag GmbH","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.3238\/arztebl.2017.0473","type":"journal-article","created":{"date-parts":[[2018,5,2]],"date-time":"2018-05-02T09:29:13Z","timestamp":1525253353000},"source":"Crossref","is-referenced-by-count":6,"title":["Aspirin Before Elective Surgery\u2014Stop or Continue?"],"prefix":"10.3238","author":[{"given":"Lili","family":"Pl\u00fcmer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Moritz","family":"Seiffert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark Andree","family":"Punke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan Felix","family":"Kersten","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefan","family":"Blankenberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Z\u00f6llner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Petzoldt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"11437","published-online":{"date-parts":[[2017,7,10]]},"reference":[{"key":"10.3238\/arztebl.2017.0473_ref1","doi-asserted-by":"crossref","unstructured":"Baigent C, Blackwell L, Collins R, et al.: Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials. Lancet 2009; 373: 1849\u201360","DOI":"10.1016\/S0140-6736(09)60503-1"},{"key":"10.3238\/arztebl.2017.0473_ref2","doi-asserted-by":"crossref","unstructured":"Bibbins-Domingo K: Aspirin use for the primary prevention of cardiovascular disease and colorectal cancer: U.S. Preventive Services Task Force Recommendation statement. Ann Intern Med 2016; 164: 836\u201345","DOI":"10.7326\/M16-0577"},{"key":"10.3238\/arztebl.2017.0473_ref3","doi-asserted-by":"crossref","unstructured":"Williams CD, Chan AT, Elman MR, et al.: Aspirin use among adults in the U.S.: results of a national survey. Am J Prev Med 2015; 48: 501\u20138","DOI":"10.1016\/j.amepre.2014.11.005"},{"key":"10.3238\/arztebl.2017.0473_ref4","doi-asserted-by":"crossref","unstructured":"Knopf H, Grams D: Arzneimittelanwendung von Erwachsenen in Deutschland. Ergebnisse der Studie zur Gesundheit Erwachsener in Deutschland (DEGS1). Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 2013; 56: 868\u201377","DOI":"10.1007\/s00103-013-1667-8"},{"key":"10.3238\/arztebl.2017.0473_ref5","doi-asserted-by":"crossref","unstructured":"Alcock RF, Reddel CJ, Pennings GJ, Hillis GS, Curnow JL, Brieger DB: The rebound phenomenon after aspirin cessation: the biochemical evidence. Int J Cardiol 2014; 174: 376\u20138","DOI":"10.1016\/j.ijcard.2014.03.192"},{"key":"10.3238\/arztebl.2017.0473_ref6","doi-asserted-by":"crossref","unstructured":"Rodriguez LA, Cea-Soriano L, Martin-Merino E, Johansson S: Discontinuation of low dose aspirin and risk of myocardial infarction: case-control study in UK primary care. BMJ 2011; 343: d4094","DOI":"10.1136\/bmj.d4094"},{"key":"10.3238\/arztebl.2017.0473_ref7","doi-asserted-by":"crossref","unstructured":"Biondi-Zoccai GG, Lotrionte M, Agostoni P, et al.: A systematic review and meta-analysis on the hazards of discontinuing or not adhering to aspirin among 50, 279 patients at risk for coronary artery disease. Eur Heart J 2006; 27: 2667\u201374","DOI":"10.1093\/eurheartj\/ehl334"},{"key":"10.3238\/arztebl.2017.0473_ref8","doi-asserted-by":"crossref","unstructured":"Gosswald A, Schienkiewitz A, Nowossadeck E, Busch MA: Pr\u00e4valenz von Herzinfarkt und koronarer Herzkrankheit bei Erwachsenen im Alter von 40 bis 79 Jahren in Deutschland \u2013 Ergebnisse der Studie zur Gesundheit Erwachsener in Deutschland (DEGS1). Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 2013; 56: 650\u20135","DOI":"10.1007\/s00103-013-1666-9"},{"key":"10.3238\/arztebl.2017.0473_ref9","doi-asserted-by":"crossref","unstructured":"van Buuren F: Bericht \u00fcber die Leistungszahlen der Herzkatheterlabore in der Bundesrepublik Deutschland. Kardiologe 2010; 4: 502\u20138","DOI":"10.1007\/s12181-010-0297-8"},{"key":"10.3238\/arztebl.2017.0473_ref10","doi-asserted-by":"crossref","unstructured":"Kristensen SD, Knuuti J, Saraste A, et al.: 2014 ESC\/ESA Guidelines on non-cardiac surgery: cardiovascular assessment and management: The Joint Task Force on non-cardiac surgery: cardiovascular assessment and management of the European Society of Cardiology (ESC) and the European Society of Anaesthesiology (ESA). Eur Heart J 2014; 35: 2383\u2013431","DOI":"10.1093\/eurheartj\/ehu282"},{"key":"10.3238\/arztebl.2017.0473_ref11","doi-asserted-by":"crossref","unstructured":"Devereaux PJ, Goldman L, Cook DJ, Gilbert K, Leslie K, Guyatt GH: Perioperative cardiac events in patients undergoing noncardiac surgery: a review of the magnitude of the problem, the pathophysiology of the events and methods to estimate and communicate risk. CMAJ 2005; 173: 627\u201334","DOI":"10.1503\/cmaj.050011"},{"key":"10.3238\/arztebl.2017.0473_ref12","doi-asserted-by":"crossref","unstructured":"Berger PB, Kleiman NS, Pencina MJ, et al.: Frequency of major noncardiac surgery and subsequent adverse events in the year after drug-eluting stent placement results from the EVENT (Evaluation of Drug-Eluting Stents and Ischemic Events) Registry. JACC Cardiovasc Interv 2010; 3: 920\u20137","DOI":"10.1016\/j.jcin.2010.03.021"},{"key":"10.3238\/arztebl.2017.0473_ref13","doi-asserted-by":"crossref","unstructured":"Cruden NL, Harding SA, Flapan AD, et al.: Previous coronary stent implantation and cardiac events in patients undergoing noncardiac surgery. Circ Cardiovasc Interv 2010; 3: 236\u201342","DOI":"10.1161\/CIRCINTERVENTIONS.109.934703"},{"key":"10.3238\/arztebl.2017.0473_ref14","doi-asserted-by":"crossref","unstructured":"Gandhi NK, Abdel-Karim AR, Banerjee S, Brilakis ES: Frequency and risk of noncardiac surgery after drug-eluting stent implantation. Catheter Cardiovasc Interv 2011; 77: 972\u20136","DOI":"10.1002\/ccd.22744"},{"key":"10.3238\/arztebl.2017.0473_ref15","doi-asserted-by":"crossref","unstructured":"Hawn MT, Graham LA, Richman JR, et al.: The incidence and timing of noncardiac surgery after cardiac stent implantation. J Am Coll Surg 2012; 214: 658\u201366","DOI":"10.1016\/j.jamcollsurg.2011.12.011"},{"key":"10.3238\/arztebl.2017.0473_ref16","doi-asserted-by":"crossref","unstructured":"Hawn MT, Graham LA, Richman JS, Itani KM, Henderson WG, Maddox TM: Risk of major adverse cardiac events following noncardiac surgery in patients with coronary stents. JAMA 2013; 310: 1462\u201372","DOI":"10.1001\/jama.2013.278787"},{"key":"10.3238\/arztebl.2017.0473_ref17","doi-asserted-by":"crossref","unstructured":"Wijeysundera DN, Wijeysundera HC, Yun L, et al.: Risk of elective major noncardiac surgery after coronary stent insertion: a population-based study. Circulation 2012; 126: 1355\u201362","DOI":"10.1161\/CIRCULATIONAHA.112.102715"},{"key":"10.3238\/arztebl.2017.0473_ref18","doi-asserted-by":"crossref","unstructured":"Albaladejo P, Marret E, Samama CM, et al.: Non-cardiac surgery in patients with coronary stents: the RECO study. Heart 2011; 97: 1566\u201372","DOI":"10.1136\/hrt.2011.224519"},{"key":"10.3238\/arztebl.2017.0473_ref19","doi-asserted-by":"crossref","unstructured":"Ferrari E, Benhamou M, Cerboni P, Marcel B: Coronary syndromes following aspirin withdrawal: a special risk for late stent thrombosis. J Am Coll Cardiol 2005; 45: 456\u20139","DOI":"10.1016\/j.jacc.2004.11.041"},{"key":"10.3238\/arztebl.2017.0473_ref20","doi-asserted-by":"crossref","unstructured":"Rossini R, Capodanno D, Lettieri C, et al.: Prevalence, predictors, and long-term prognosis of premature discontinuation of oral antiplatelet therapy after drug eluting stent implantation. Am J Cardiol 2011; 107: 186\u201394","DOI":"10.1016\/j.amjcard.2010.08.067"},{"key":"10.3238\/arztebl.2017.0473_ref21","doi-asserted-by":"crossref","unstructured":"Rossini R, Musumeci G, Capodanno D, et al.: Perioperative management of oral antiplatelet therapy and clinical outcomes in coronary stent patients undergoing surgery. Results of a multicentre registry. Thromb Haemost 2015; 113: 272\u201382","DOI":"10.1160\/TH14-05-0436"},{"key":"10.3238\/arztebl.2017.0473_ref22","doi-asserted-by":"crossref","unstructured":"Devereaux PJ, Mrkobrada M, Sessler DI, et al.: Aspirin in patients undergoing noncardiac surgery. N Engl J Med 2014; 370: 1494\u2013503","DOI":"10.1016\/j.jvs.2014.06.094"},{"key":"10.3238\/arztebl.2017.0473_ref23","doi-asserted-by":"crossref","unstructured":"Fleisher LA, Fleischmann KE, Auerbach AD, et al.: 2014 ACC\/AHA guideline on perioperative cardiovascular evaluation and management of patients undergoing noncardiac surgery: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines. Circulation 2014; 130: e278\u2013333","DOI":"10.1161\/CIR.0000000000000104"},{"key":"10.3238\/arztebl.2017.0473_ref24","doi-asserted-by":"crossref","unstructured":"Gerstein NS, Carey MC, Cigarroa JE, Schulman PM: Perioperative aspirin management after POISE-2: some answers, but questions remain. Anesth Analg 2015; 120: 570\u20135","DOI":"10.1213\/ANE.0000000000000589"},{"key":"10.3238\/arztebl.2017.0473_ref25","doi-asserted-by":"crossref","unstructured":"Schlitt A, Jambor C, Spannagl M, Gogarten W, Schilling T, Zwissler B: The perioperative management of treatment with anticoagulants and platelet aggregation inhibitors. Dtsch Arztebl Int 2013; 110: 525\u201332","DOI":"10.3238\/arztebl.2013.0525"},{"key":"10.3238\/arztebl.2017.0473_ref26","doi-asserted-by":"crossref","unstructured":"Douketis JD, Spyropoulos AC, Spencer FA, et al.: Perioperative management of antithrombotic therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2012; 141: e326S\u201350S.","DOI":"10.1378\/chest.11-2298"},{"key":"10.3238\/arztebl.2017.0473_ref27","doi-asserted-by":"crossref","unstructured":"Jambor C, von Pape KW, Spannagl M, Dietrich W, Giebl A, Weisser H: Multiple electrode whole blood aggregometry, PFA-100, and in vivo bleeding time for the point-of-care assessment of aspirin-induced platelet dysfunction in the preoperative setting. Anesth Analg 2011; 113: 31\u20139","DOI":"10.1213\/ANE.0b013e31821acddc"},{"key":"10.3238\/arztebl.2017.0473_ref28","doi-asserted-by":"crossref","unstructured":"Zisman E, Erport A, Kohanovsky E, et al.: Platelet function recovery after cessation of aspirin: preliminary study of volunteers and surgical patients. Eur J Anaesthesiol 2010; 27: 617\u201323","DOI":"10.1097\/EJA.0b013e328335b354"},{"key":"10.3238\/arztebl.2017.0473_ref29","doi-asserted-by":"crossref","unstructured":"Koenig-Oberhuber V, Filipovic M: New antiplatelet drugs and new oral anticoagulants. Br J Anaesth 2016; 117 Suppl 2: ii74\u2013ii84","DOI":"10.1093\/bja\/aew214"},{"key":"10.3238\/arztebl.2017.0473_ref30","doi-asserted-by":"crossref","unstructured":"Hallgren KA: Computing inter-rater reliability for observational data: an overview and tutorial. Tutor Quant Methods Psychol 2012; 8: 23\u201334","DOI":"10.20982\/tqmp.08.1.p023"},{"key":"10.3238\/arztebl.2017.0473_ref31","unstructured":"R Core Team: R: a language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. www.r-project.org (last accessed on on 8 May 2017)."},{"key":"10.3238\/arztebl.2017.0473_ref32","doi-asserted-by":"crossref","unstructured":"Petzoldt M, Kahler J, Goetz AE, Friederich P: Perioperative medikament\u00f6se Kardioprotektion. Systematische Literatur\u00fcbersicht als rationale Grundlage zur Prozessoptimierung. Anaesthesist 2008; 57: 655\u201369","DOI":"10.1007\/s00101-008-1396-9"},{"key":"10.3238\/arztebl.2017.0473_ref33","doi-asserted-by":"crossref","unstructured":"Duceppe E, Mrkobrada M, Thomas S, Devereaux PJ: Role of aspirin for prevention and treatment of perioperative cardiovascular events. J Thromb Haemost 2015; 13 Suppl 1: S297\u2013303","DOI":"10.1111\/jth.12975"},{"key":"10.3238\/arztebl.2017.0473_ref34","doi-asserted-by":"crossref","unstructured":"Kiberd MB, Hall RI: Aspirin in the perioperative period: a review of the recent literature. Curr Opin Anaesthesiol 2015; 28: 349\u201355","DOI":"10.1097\/ACO.0000000000000200"},{"key":"10.3238\/arztebl.2017.0473_ref35","doi-asserted-by":"crossref","unstructured":"Burger W, Chemnitius JM, Kneissl GD, Rucker G: Low-dose aspirin for secondary cardiovascular prevention\u2014cardiovascular risks after its perioperative withdrawal versus bleeding risks with its continuation\u2013review and meta-analysis. J Intern Med 2005; 257: 399\u2013414","DOI":"10.1111\/j.1365-2796.2005.01477.x"},{"key":"10.3238\/arztebl.2017.0473_ref36","doi-asserted-by":"crossref","unstructured":"Gerstein NS, Charlton GA: Questions linger over POISE-2 and perioperative aspirin management. Evid Based Med 2014; 19: 224\u20135","DOI":"10.1136\/ebmed-2014-110035"},{"key":"10.3238\/arztebl.2017.0473_ref37","doi-asserted-by":"crossref","unstructured":"Mantz J, Samama CM, Tubach F, et al.: Impact of preoperative maintenance or interruption of aspirin on thrombotic and bleeding events after elective non-cardiac surgery: the multicentre, randomized, blinded, placebo-controlled, STRATAGEM trial. Br J Anaesth 2011; 107: 899\u2013910","DOI":"10.1093\/bja\/aer274"},{"key":"10.3238\/arztebl.2017.0473_ref38","doi-asserted-by":"crossref","unstructured":"Oscarsson A, Gupta A, Fredrikson M, et al.: To continue or discontinue aspirin in the perioperative period: a randomized, controlled clinical trial. Br J Anaesth 2010; 104: 305\u201312","DOI":"10.1093\/bja\/aeq003"},{"key":"10.3238\/arztebl.2017.0473_ref39","unstructured":"Sabat\u00e9 E: Adherence to long-term therapies: evidence for action. Geneva, Switzerland: World Health Organization 2003. www.who.int\/chp\/knowledge\/publications\/adherence_report\/en\/ (last accessed on 8 May 2017)."},{"key":"10.3238\/arztebl.2017.0473_ref40","doi-asserted-by":"crossref","unstructured":"Matthes J, Albus C: Improving adherence with medication\u2014a selective literature review based on the example of hypertension treatment. Dtsch Arztebl Int 2014; 111: 41\u20137","DOI":"10.3238\/arztebl.2014.0041"}],"container-title":["Deutsches \u00c4rzteblatt international"],"original-title":[],"link":[{"URL":"https:\/\/www.aerzteblatt.de\/10.3238\/arztebl.2017.0473","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,7]],"date-time":"2021-12-07T10:28:32Z","timestamp":1638872912000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.aerzteblatt.de\/10.3238\/arztebl.2017.0473"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7,10]]},"references-count":40,"URL":"https:\/\/doi.org\/10.3238\/arztebl.2017.0473","relation":{},"ISSN":["1866-0452"],"issn-type":[{"value":"1866-0452","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,7,10]]}}}